Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
VSEE · 10-Q filed August 14, 2026

VSEE earnings analysis

What we found in VSEE's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

The filing provides no current-quarter income statement, balance-sheet, cash-flow, or segment values in the supplied extract, so revenue, margins, EPS, and free cash flow are left null. The principal developments are ineffective disclosure controls as of June 30, 2026, Nasdaq trading suspension on August 6, 2026 following a $0.10 bid-price issue, and an $845,891 vendor lawsuit. Overall risk has increased materially because management links remediation to additional funding and warns of possible financing defaults if trading does not resume.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Finance Leases Fully Settled
The filing states that the Company’s finance lease obligations were fully settled as of June 30, 2026, reducing that specific liability burden.
Accounting Remediation Plan
Management disclosed a remediation plan involving enhanced accounting research access and communication with third-party professionals, although it stated the initiatives can only be completed over time.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Material Weaknesses in Controls
Disclosure controls were deemed ineffective as of June 30, 2026. Material weaknesses include insufficient accounting personnel, ineffective IT general controls, lack of a formal control environment, and improper accounting for significant or non-recurring transactions.
Nasdaq Delisting and Liquidity Risk
Nasdaq delisted the Company’s securities after the stock closed at $0.10 or less for 10 consecutive trading days; trading was suspended on August 6, 2026. The Company expects OTC Pink trading, which may reduce share liquidity and impair access to capital.
$845,891 Vendor Lawsuit
Toppan Merrill filed a lawsuit seeking $845,891 for services and a preliminary injunction restricting asset dispositions. The Company has accrued an amount it considers reasonable, but the claim could further pressure liquidity and management resources.
Funding Required for Remediation
Management stated that the identified control weaknesses will not be remediated until the Company receives additional funding, while also stating it cannot assure timely remediation.
Potential Financing Defaults
If the common stock cannot resume trading on any market, the Company may face cash payment obligations and defaults under existing financing arrangements, further straining liquidity and its ability to continue as a going concern.
Guidance

What they said about what is next.

No quantitative revenue or EPS outlook was provided in the filing; numeric guidance remains unavailable.

How we read the filing overall

The filing reads worse than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · May 15, 2026
VSee Health reported a decrease in revenue this quarter, down 5% year-over-year to $3,160,185. The net loss also decreased to $2,600,262, a significant improvement from the prior year's loss of $3,959,440. Management…
10-K · March 31, 2026
VSee Health positions itself as a clinician-first telehealth platform (VSee Lab) with a complementary high-acuity tele-ICU and federal e-consult business (iDoc). Revenue is small and volatile (Q4 revenue $3,925,925)…
10-Q · October 15, 2025
VSee Health reported total revenue of $3,321,485 for the three months ended March 31, 2025, up from $1,620,995 in the prior-year quarter, driven by new Telehealth service revenue. Despite top-line growth, the company…
10-K · August 28, 2025
VSee’s 10-K emphasizes a clinician-centric telehealth strategy built around its VSee Lab no-code/low-code building blocks and a high-acuity services subsidiary (iDoc). The filing discloses product and compliance…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing VSEE makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever